Lei Xi

868 total citations
56 papers, 612 citations indexed

About

Lei Xi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lei Xi has authored 56 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lei Xi's work include RNA modifications and cancer (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Lei Xi is often cited by papers focused on RNA modifications and cancer (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Lei Xi collaborates with scholars based in China, United States and Singapore. Lei Xi's co-authors include Zhengcheng Liu, Lichun Deng, Rusong Yang, Hui Cao, Shulin Zhuang, Song Xu, Mei Liu, Lian Jin, Nongyue He and Zhifei Wang and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Lei Xi

46 papers receiving 610 citations

Peers

Lei Xi
Comparison fields: 5 of 87
  • Molecular Biology 336
  • Cancer Research 226
  • Pulmonary and Respiratory Medicine 196
  • Oncology 147
  • Surgery 42
Replace Yisheng Fang with:
Yisheng Fang United States
Subhash Haldar United States
Zihao Chen China
Junhua Zhang China
Justin Markel United States
Ana Iulia Neagu Romania
Chunyu Hou China
Jiongke Wang China
Cai Cheng China
Yuka Kitamura Japan
Yisheng Fang United States View profile →
Citations per field, relative to Lei Xi
Lei Xi · 1×
Citations per year, relative to Lei Xi
Lei Xi · 1×

Countries citing papers authored by Lei Xi

Since Specialization
Citations

This map shows the geographic impact of Lei Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Xi more than expected).

Fields of papers citing papers by Lei Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Xi. The network helps show where Lei Xi may publish in the future.

Co-authorship network of co-authors of Lei Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Xi. A scholar is included among the top collaborators of Lei Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Xi. Lei Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 0
4 0
5 9
6
The Role of OCTA in Evaluating Diabetic Retinopathy Progression: A Meta-Analysis.
2
7 2
8 0
9 12
10 10
11 3
12 15
13 8
14 9
15 13
16 4
17 2
18 5
19 20
20 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026